Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 1, 2008, Pages 209-216

  Johnson, Bankole A ^a   Javors, Martin A ^b   Roache, John D ^b   Seneviratne, Chamindi ^a   Bergeson, Susan E ^c   Ait Daoud, Nassima ^a   Dawes, Michael A ^d   Ma, Jennie Z ^e  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Alcohol dependence; Genotype; Humans; Paroxetine; Platelet; Serotonin transporter

Indexed keywords

FLUOXETINE; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CHRONICITY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DRINKING BEHAVIOR; DRUG BINDING; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; THROMBOCYTE FUNCTION;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; BLOOD PLATELETS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 38349057740     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.07.030     Document Type: Article

References (49)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington, D.C.
2. Baumgarten H.G., and Grozdanovic Z. Anatomy of central serotoninergic projection systems. In: Baumgarten H.G., and Gothert M. (Eds). Handbook of experimental pharmacology. Serotoninergic neurons and 5-HT receptors in the CNS vol. 129 (1997), Springer, New York 41-89
3. Beckman M.L., and Quick M.W. Neurotransmitter transporters: regulators of function and functional regulation. J Membr Biol 164 (1998) 1-10
4. Bohn M.J., Babor T.F., and Kranzler H.R. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol 56 (1995) 423-432
5. Cesura A.M., Bertocci B., and Da Prada M. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles. Eur J Pharmacol 186 (1990) 95-104
6. Chick J., Aschauer H., Hornik K., and Investigators' Group. Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology. Drug Alcohol Depend 74 (2004) 61-70
7. Da Prada M., Cesura A.M., Launay J.M., and Richards J.G. Platelets as a model for neurones?. Experientia 44 (1988) 115-126
8. Dundon W., Lynch K.G., Pettinati H.M., and Lipkin C. Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy. Alcohol Clin Exp Res 28 (2004) 1065-1073
9. Esterling L.E., Yoshikawa T., Turner G., Badner J.A., Bengel D., Gershon E.S., et al. Serotonin transporter (5-HTT) gene and bipolar affective disorder. Am J Med Genet 81 (1998) 37-40
10. Feinn R., Nellissery M., and Kranzler H.R. Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 133 (2005) 79-84
11. Gill K., and Amit Z. Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies. Recent Dev Alcohol 7 (1989) 225-248
12. Greenberg B.D., Tolliver T.J., Huang S.J., Li Q., Bengel D., and Murphy D.L. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88 (1999) 83-87
13. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 66 (1996) 2621-2624
14. Heils A., Mossner R., and Lesch K.P. The human serotonin transporter gene polymorphism-basic research and clinical implications. J Neural Transm 104 (1997) 1005-1014
15. Heinz A., Jones D.W., Mazzanti C., Goldman D., Ragan P., Hommer D., et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 47 (2000) 643-649
16. Heinz A., Jones D.W., Gorey J.G., Bennet A., Suomi S.J., Weinberger D.R., et al. Serotonin transporter availability correlates with alcohol intake in non-human primates. Mol Psychiatry 8 (2003) 231-234
17. Heinz A., Goldman D., Gallinat J., Schumann G., and Puls I. Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence. Psychopharmacology 174 (2004) 561-570
18. Herman A.I., Kaiss K.M., Ma R., Philbeck J.W., Hasan A., Dasti H., et al. Serotonin transporter promoter polymorphism and monoamine oxidase type A VNTR allelic variants together influence alcohol binge drinking risk in young women. Am J Med Genet B Neuropsychiatr Genet 133 (2005) 74-78
19. Javors M.A., Houston J.P., Tekell J.L., Brannan S.K., and Frazer A. Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. Int J Neuropsychopharmacol 3 (2000) 229-235
20. Javors M.A., Seneviratne C., Roache J.D., Ait-Daoud N., Bergeson S.E., Walss-Bass M.C., et al. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 7-13
21. Johnson B.A. Serotonergic agents and alcoholism treatment: rebirth of the subtype concept-an hypothesis. Alcohol Clin Exp Res 24 (2000) 1597-1601
22. Johnson B.A., and Ait-Daoud N. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology 149 (2000) 327-344
23. Köhnke M.D., Kolb W., Lutz U., Maurer S., and Batra A. The serotonin transporter promoter polymorphism 5-HTTLPR is not associated with alcoholism or severe forms of alcohol withdrawal in a German sample. Psychiatr Genet 16 (2006) 227-228
24. Kranzler H.R., Burleson J.A., Brown J., and Babor T.F. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin Exp Res 20 (1996) 1534-1541
25. Kweon Y.S., Lee H.K., Lee C.T., Lee K.U., and Pae C.U. Association of the serotonin transporter gene polymorphism with Korean male alcoholics. J Psychiatr Res 39 (2005) 371-376
26. LeMarquand D., Pihl R.O., and Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psychiatry 36 (1994) 395-421
27. LeMarquand D., Pihl R.O., and Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol Psychiatry 36 (1994) 326-337
28. Lesch K.P., Wolozin B.L., Murphy D.L., and Reiderer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 60 (1993) 2319-2322
29. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
30. Lesch K.P., Greenberg B.D., and Higley J.D. Serotonin transporter, personality, and behavior: toward dissection of gene-gene and gene-environment interaction. In: Benjamin J., Ebstein R.P., and Belmaker R.H. (Eds). Molecular genetics and the human personality (2002), American Psychiatric Publishing, Washington, D.C. 109-136
31. Little K.Y., McLaughlin D.P., Zhang L., Livermore C.S., Dalack G.W., McFinton P.R., et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155 (1998) 207-213
32. McBride W.J., and Li T.K. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 12 (1998) 339-369
33. Modai I., Malmgren R., Asberg M., and Beving H. Circadian rhythm of serotonin transport in human platelets. Psychopharmacology 88 (1986) 493-495
34. Modai I., Malmgren R., Wetterberg L., Eneroth P., Valevski A., and Asberg M. Blood levels of melatonin, serotonin, cortisol, and prolactin in relation to the circadian rhythm of platelet serotonin uptake. Psychiatry Res 43 (1992) 161-166
35. Naranjo C.A., and Knoke D.M. The role of selective serotonin reuptake inhibitors in reducing alcohol consumption. J Clin Psychiatry 62 (2001) 18-25
36. Olsson C.A., Byrnes G.B., Lotfi-Miri M., Collins V., Williamson R., Patton C., et al. Association between 5-HTTLPR genotypes and persisting patterns of anxiety and alcohol use: results from a 10-year longitudinal study of adolescent mental health. Mol Psychiatry 10 (2005) 868-876
37. Penington D.G. Formation of platelets. In: Gordon J.L. (Ed). Platelets in biology and pathology 2 (1981), Elsevier/North-Holland Biomedical Press, New York 19-41
38. Pettinati H.M., Volpicelli J.R., Kranzler H.R., Luck G., Rukstalis M.R., and Cnaan A. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res 24 (2000) 1041-1049
39. Pettinati H.M., Volpicelli J.R., Luck G., Kranzler H.R., Rukstalis M.R., and Cnaan A. Double-blind clinical trial of sertraline treatment for alcohol dependence. J Clin Psychopharmacol 21 (2001) 143-153
40. Preuss U.W., Soyka M., Bahlmann M., Wenzel K., Behrens S., de Jonge S., et al. Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity. Psychiatry Res 96 (2000) 51-61
41. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A 90 (1993) 2542-2546
42. Samochowiec J., Kucharska-Mazur J., Grzywacz A., Jablonski M., Rommelspacher H., Samochowiec A., et al. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence. Neurosci Lett 410 (2006) 1-5
43. Sander T., Harms H., Lesch K.P., Dufeu P., Kuhn S., Hoehe M., et al. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcohol Clin Exp Res 21 (1997) 1356-1359
44. Sloan T.B., Roache J.D., and Johnson B.A. The role of anxiety in predicting drinking behaviour. Alcohol Alcohol 38 (2003) 360-363
45. Sobell L.C., and Sobell M.B. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten R.Z., and Allen J.P. (Eds). Measuring alcohol consumption: psychosocial and biochemical methods (1992), Humana Press Inc., Totowa, NJ 41-72
46. Stoltenberg S.F. Serotonergic agents and alcoholism treatment: a simulation. Alcohol Clin Exp Res 27 (2003) 1853-1859
47. Villinger F., Faraj B.A., Olkowski Z.L., Jackson R.T., and Ansari A.A. Functional expression of the serotonin transporter in human peripheral lymphocytes. FASEB J 8 (1994) A108
48. Virkkunen M., and Linnoila M. Serotonin in early-onset alcoholism. In: Galanter M. (Ed). Recent developments in alcoholism, alcohol and violence: epidemiology, neurobiology, psychology, family issues (1997), Plenum Press, New York 173-189
49. Virkkunen M., Goldman D., Nielsen D.A., and Linnoila M. Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J Psychiatry Neurosci 20 (1995) 271-275